Unit 4: Radioimmune Assay & Extraction Techniques

March 18, 2026

Semester 8
BP811T

Radioimmune Assay & Extraction Techniques

This unit covers two critically important analytical capabilities: Radioimmune Assay (RIA)—one of the most sensitive quantification techniques ever developed, capable of measuring analytes at picogram levels using radioactive labels and antibody specificity—and the essential Sample Preparation techniques (Solid-Phase Extraction and Liquid-Liquid Extraction) that clean up and concentrate analytes from complex biological matrices before instrumental analysis.

Syllabus & Topics

  • 1Radioimmune Assay (RIA) – Importance & Principle: Importance: RIA was one of the first techniques to quantify substances at extremely low concentrations (picograms to nanograms per mL) in biological fluids. Revolutionized clinical endocrinology, pharmacokinetics, and therapeutic drug monitoring. Rosalyn Yalow received the 1977 Nobel Prize for its development. Principle: Competitive Binding Assay. A FIXED amount of radiolabeled antigen (tracer) and the UNKNOWN sample antigen compete for binding to a LIMITED amount of specific antibody. The more unlabeled antigen in the sample → the more tracer is displaced from the antibody → less radioactivity in the antibody-bound fraction. The bound radioactivity is inversely proportional to the concentration of unlabeled antigen in the sample.
  • 2RIA – Components & Methods: Components: (1) Antigen (Analyte): The substance being measured (e.g., Insulin, T3, T4, Cortisol, drugs like Digoxin). (2) Specific Antibody: Highly specific polyclonal or monoclonal antibodies raised against the antigen. (3) Radiolabeled Tracer: The antigen labeled with a radioactive isotope (commonly ¹²⁵I—Iodine-125, a gamma emitter with 60-day half-life). (4) Standard Curve: Prepared using known concentrations of unlabeled antigen. The bound radioactivity (B) at each standard concentration is plotted vs. concentration → sigmoidal calibration curve. (5) Separation System: Separates antibody-bound tracer from free tracer. Methods: Double Antibody (Second antibody precipitates the Ab-Ag complex), Charcoal Adsorption (activated charcoal adsorbs free tracer), PEG Precipitation, Solid-phase (antibody immobilized on tube/bead).
  • 3RIA – Limitations & Applications: Limitations: (1) Radioactive hazard: Requires radiation safety licenses, specialized waste disposal, and personnel monitoring. (2) Short reagent shelf life: ¹²⁵I tracers decay (60-day half-life), requiring frequent re-preparation. (3) Cannot distinguish between parent drug and metabolites with similar structures (cross-reactivity). (4) Being increasingly replaced by non-radioactive alternatives (ELISA, Chemiluminescence Immunoassay). Applications: Quantification of: Hormones (Insulin, Thyroid hormones T3/T4, Cortisol, Growth Hormone, Testosterone), Therapeutic Drug Monitoring (Digoxin, Cyclosporine, Gentamicin), Tumor Markers (CEA, AFP, PSA), Drugs of Abuse screening, Vitamin levels (B12, Folate).
  • 4Solid-Phase Extraction (SPE): Principle: SPE is a sample preparation technique that uses a small disposable cartridge packed with sorbent material to selectively adsorb the analyte from a liquid matrix, wash away interferences, and then elute the purified analyte with a suitable solvent. Procedure: Step 1: Conditioning – Wet the sorbent with organic solvent (MeOH) followed by aqueous buffer to activate binding sites. Step 2: Sample Loading – Pass the biological sample (plasma, urine) through the cartridge. Analyte binds to the sorbent; matrix components pass through. Step 3: Washing – Wash with a mild solvent to remove weakly bound interferences without eluting the analyte. Step 4: Elution – Use a strong solvent to elute the purified, concentrated analyte for analysis. Types of Sorbents: Reversed-Phase (C18, C8—retains non-polar analytes), Normal-Phase (Silica, Alumina—retains polar analytes), Ion-Exchange (SAX, SCX—retains charged analytes), Mixed-Mode (combination). Advantages: High recovery, excellent cleanup, automation-compatible, wide sorbent selection.
  • 5Liquid-Liquid Extraction (LLE): Principle: Based on the differential partitioning of an analyte between two immiscible liquid phases (typically aqueous sample and an organic solvent). The analyte preferentially distributes into one phase based on its partition coefficient (Kd = Corganic/Caqueous). Procedure: Step 1: The aqueous biological sample (plasma, serum) is placed in a separating funnel. Step 2: An immiscible organic solvent (Diethyl ether, Ethyl acetate, Dichloromethane, Hexane) is added. Step 3: The funnel is shaken vigorously to maximize contact between phases, allowing the analyte to partition into the organic layer. Step 4: The layers separate—the organic phase (containing the analyte) is collected. Step 5: The organic solvent is evaporated, and the residue is reconstituted in mobile phase for HPLC/GC analysis. pH Manipulation: For ionizable drugs, pH is adjusted to ensure the drug is in its UNIONIZED (non-polar) form, maximizing partitioning into the organic phase (e.g., acidic drugs—lower pH; basic drugs—raise pH). Multiple extractions improve recovery (Craig’s equation). Disadvantages: Labor-intensive, large solvent volumes, emulsion formation, environmental solvent waste.

Learning Objectives

Explain RIA Principle: Describe the competitive binding mechanism of RIA, explaining why bound radioactivity is INVERSELY proportional to the sample antigen concentration.
Construct RIA Standard Curve: Outline the step-by-step procedure for preparing an RIA standard curve and explain how an unknown sample concentration is determined from it.
Compare SPE vs. LLE: Contrast Solid-Phase Extraction and Liquid-Liquid Extraction based on principle, selectivity, solvent usage, automation potential, and suitability for different analyte types.
Design SPE Protocol: Given an acidic drug in a plasma sample, select the appropriate SPE sorbent (C18) and outline the complete 4-step protocol (Condition → Load → Wash → Elute).
Apply pH Manipulation: Explain why adjusting the pH of a plasma sample to 2.0 before LLE extraction of an acidic drug (pKa = 4.5) dramatically improves recovery into the organic phase.

Exam Prep Questions

Q1. Why is RIA being replaced by ELISA and Chemiluminescence assays?

Radioimmunoassay (RIA) uses radioactive isotopes, which pose safety hazards, require strict regulatory controls, and have limited shelf life due to radioactive decay. ELISA replaces radioactive labels with enzyme-based detection, offering similar sensitivity without safety concerns. Chemiluminescence immunoassays go a step further by using light-emitting reactions, providing even higher sensitivity and allowing full automation on modern analyzers. These advantages make ELISA and chemiluminescence safer, more efficient alternatives to RIA.

Q2. Why do we need sample preparation (SPE/LLE) before HPLC analysis?

Biological samples like blood and plasma contain complex mixtures of proteins, lipids, and other interfering substances. Direct injection into HPLC can damage the column, cause interference in detection, and produce inaccurate results. Techniques such as Solid Phase Extraction (SPE) and Liquid-Liquid Extraction (LLE) remove unwanted components and isolate the target analyte, resulting in cleaner chromatograms and more reliable quantification.

Q3. Why is pH adjustment critical in Liquid-Liquid Extraction?

The efficiency of liquid-liquid extraction depends on whether a drug is in its ionized or unionized form. Ionized molecules are water-soluble and remain in the aqueous phase, while unionized molecules are more lipophilic and partition into the organic phase. By adjusting the pH (using the Henderson-Hasselbalch principle), the drug can be converted into its unionized form, significantly improving extraction efficiency and recovery.